I sure hope the ZE team makes continued and quick progress on TNBC because they have competition.

Posted by The Canadian Cancer Society;

TNBC Feb 19 2023

Canadian Cancer Society 

https://www.facebook.com/?__cft__%5B0%5D=AZU46pCAM0o1WUcmBiN1QkwqyBZS7xPjaMPyU9FsqhabmY3ZGTX91CeWKG0fg19XliR4k9K5vF6tkLiP1chey0AtholL_vlKFspne_s1aB933eFSYxPavSsUnI8x2FygUZQLXXPakzZ-35yWnsj1agZjZneGLVOJDPYqDLc2R6ee7sx9YzgsBAHNB4rMFXdSKg8yvRbhe_emfu8Xg0V98P1KD9kaILrlVm26tgjMKaTPiElYvjQJXxc-75Tbf0V9FCDF_uNvlKsMHGMiF6bBiAbb143Vg6I60RDxWiR2xIqMmnMT7lkAm-_HZIXURil4HYI&__tn__=%2CP-R - ?dgc  · 

Learn more about research at CCS: https://bit.ly/414SiZo

Triple negative breast cancer is the deadliest form of breast cancer. However, a new triple combination treatment approach could help improve outcomes for people with the disease.

The strategy combines cancer-killing viruses, surgery and immunotherapy drugs called immune checkpoint inhibitors to provide long-term benefits and prevent relapse. With support from CCS, Dr Jean-Simon Diallo and other researchers found that giving cancer-killing viruses before surgery led to a strong anti-tumour immune response. This significantly improved the effectiveness of immunotherapy drugs given after surgery.

If this promising new approach is validated in clinical trials, it could significantly change the treatment landscape for people with this aggressive cancer and help them live longer.

Go ZE team, go!

GLTA

Toinv